Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > Some simple math
View:
Post by aussyspitz on Sep 21, 2021 12:26pm

Some simple math

According to the announcement no fractional shares will be issued and they will be rounding down so my recommendation to everyone here is to ensure whatever number of shares you own is wholly divisible by 11.74 prior to 9/23 also the NASDAQ listing documents shows that the offering price will be $6.00 if you divide that by 11.74 you get an approximate pre-consolidation share price of .51 so my conclusion is any purchase between now and Sept 23 below .51 is probably going to work out in your favor and represents a likely 15% approximate gain from the current share price of approx .44.
Comment by SpaceLabs on Sep 21, 2021 2:22pm
Where do you see this going at nasdaq once listed, will it TANK ?
Comment by aussyspitz on Sep 21, 2021 4:10pm
Short term: Stocks that uplist tend to experience an upside spike exceeding 25%. Long term: The upside spike may not be sustained as the stock price becomes more reflective of the underlying fundamentals. Bottom Line: If you are a trader trade the short term lift if you are a long term investor who believes the underlying fundamentals hold some powder and buy on the pull back ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities